HSBC Holdings
BCAB

HSBC Holdings’s BIOATLA INC BCAB Stock Holding History

HSBC Holdings’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-365
Closed -$54K – 2935
2022
Q2 		$54K Buy
365
+128
+54% +$20.4K ﹤0.01% 3126
2022
Q1 		$59K Buy
+237
New +$99.1K ﹤0.01% 3187

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

HSBC Holdings's BCAB Position: Q3 2022 in Review

HSBC Holdings sold out of BIOATLA INC (BCAB) in Q3 2022, closing a stake of 365 shares — an estimated $54K sold.

HSBC Holdings first reported a position in BCAB in Q1 2022 and held it in 2 quarters. The position peaked at $59K in Q1 2022. 73 funds tracked by Wall St. Rank hold BCAB as of Q3 2022.

  • HSBC Holdings reported no remaining BIOATLA INC position as of Q3 2022 after selling out during the quarter.
  • HSBC Holdings sold 365 BIOATLA INC shares in Q3 2022, an estimated $54K.
  • HSBC Holdings first reported a position in BIOATLA INC in Q1 2022 and held it in 2 quarters.
  • HSBC Holdings's BIOATLA INC position peaked at $59K in Q1 2022.
  • 73 funds tracked by Wall St. Rank held BIOATLA INC as of Q3 2022.

Based on HSBC Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.